How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit

Abstract Background In the UK, primary care records are electronic and require doctors to ascribe disease codes to direct care plans and facilitate safe prescribing. We investigated factors associated with coding of chronic kidney disease (CKD) in patients with reduced kidney function and the impact this has on patient management. Methods We identified patients meeting biochemical criteria for CKD (two estimated glomerular filtration rates <60 mL/min/1.73 m2 taken >90 days apart) from 1039 general practitioner (GP) practices in a UK audit. Clustered logistic regression was used to identify factors associated with coding for CKD and improvement in coding as a result of the audit process. We investigated the relationship between coding and five interventions recommended for CKD: achieving blood pressure targets, proteinuria testing, statin prescription and flu and pneumococcal vaccination. Results Of 256 000 patients with biochemical CKD, 30% did not have a GP CKD code. Males, older patients, those with more severe CKD, diabetes or hypertension or those prescribed statins were more likely to have a CKD code. Among those with continued biochemical CKD following audit, these same characteristics increased the odds of improved coding. Patients without any kidney diagnosis were less likely to receive optimal care than those coded for CKD [e.g. odds ratio for meeting blood pressure target 0.78 (95% confidence interval 0.76–0.79)]. Conclusion Older age, male sex, diabetes and hypertension are associated with coding for those with biochemical CKD. CKD coding is associated with receiving key primary care interventions recommended for CKD. Increased efforts to incentivize CKD coding may improve outcomes for CKD patients.

[1]  D. Wheeler,et al.  Accounting for overdispersion when determining primary care outliers for the identification of chronic kidney disease: learning from the National Chronic Kidney Disease Audit: Clinical Epidemiology in Nephrology , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  L. Tomlinson,et al.  Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  X. Estivill,et al.  Contribution of the TTC21B gene to glomerular and cystic kidney diseases , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Daniel P. Morin,et al.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives , 2016, Pragmatic and observational research.

[5]  Bruce Guthrie,et al.  质量与结果框架:我们学到了什么 ? Quality and Outcomes Framework : what have we learnt ? , 2016 .

[6]  S. de Lusignan,et al.  What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial , 2016, BMJ Open.

[7]  C. van Weel,et al.  Quality of chronic kidney disease management in primary care: a retrospective study , 2016, Scandinavian journal of primary health care.

[8]  D. Wheeler,et al.  Accounting for overdispersion when determining primary care outliers for the identification of chronic kidney disease : learning from the NCKDA , 2016 .

[9]  P. Roderick,et al.  Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study , 2015, BMC Family Practice.

[10]  S. Jick,et al.  Prevalence and management of chronic kidney disease in primary care patients in the UK , 2014, International journal of clinical practice.

[11]  G. Moon,et al.  Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010 , 2014, BMJ Open.

[12]  R. McManus,et al.  The Need for Improved Identification and Accurate Classification of Stages 3–5 Chronic Kidney Disease in Primary Care: Retrospective Cohort Study , 2014, PloS one.

[13]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[14]  Tom Chan,et al.  Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results , 2013, Kidney international.

[15]  M. Yaqoob,et al.  The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease , 2011, BMC nephrology.

[16]  N. Brunskill,et al.  Which factors are associated with higher rates of chronic kidney disease recording in primary care? A cross-sectional survey of GP practices. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[17]  W. G. Walker,et al.  Plasma aldosterone regulation in anephric man. , 1973, Kidney international.

[18]  L. Tomlinson,et al.  Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Daniel P. Morin,et al.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives , 2016, Pragmatic and observational research.

[20]  Bruce Guthrie,et al.  质量与结果框架:我们学到了什么 ? Quality and Outcomes Framework : what have we learnt ? , 2016 .

[21]  S. de Lusignan,et al.  What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial , 2016, BMJ Open.

[22]  D. Wheeler,et al.  Accounting for overdispersion when determining primary care outliers for the identification of chronic kidney disease : learning from the NCKDA , 2016 .

[23]  P. Roderick,et al.  Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study , 2015, BMC Family Practice.

[24]  S. Jick,et al.  Prevalence and management of chronic kidney disease in primary care patients in the UK , 2014, International journal of clinical practice.

[25]  G. Moon,et al.  Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010 , 2014, BMJ Open.

[26]  R. McManus,et al.  The Need for Improved Identification and Accurate Classification of Stages 3–5 Chronic Kidney Disease in Primary Care: Retrospective Cohort Study , 2014, PloS one.

[27]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[28]  Tom Chan,et al.  Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results , 2013, Kidney international.

[29]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[30]  M. Yaqoob,et al.  The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease , 2011, BMC nephrology.

[31]  N. Brunskill,et al.  Which factors are associated with higher rates of chronic kidney disease recording in primary care? A cross-sectional survey of GP practices. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.